Minoxidil lotion 1% — Competitive Intelligence Brief

Minoxidil lotion 1% (Minoxidil lotion 1%) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Potassium channel opener / topical hair growth stimulant. Area: Dermatology.

marketed Potassium channel opener / topical hair growth stimulant ATP-sensitive potassium channels Dermatology Small molecule

Target snapshot

Minoxidil lotion 1% (Minoxidil lotion 1%) — Mae Fah Luang University Hospital. Minoxidil is a potassium channel opener that increases blood flow to hair follicles and prolongs the anagen (growth) phase of the hair cycle.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Minoxidil lotion 1% TARGET	Minoxidil lotion 1%	Mae Fah Luang University Hospital	marketed	Potassium channel opener / topical hair growth stimulant	ATP-sensitive potassium channels
Sevoflurane (Preconditioning)	Sevoflurane (Preconditioning)	University of Zurich	marketed	Volatile anesthetic with cardioprotective preconditioning properties	Mitochondrial ATP-sensitive potassium channels (mitoKATP); protein kinase C; endothelial nitric oxide synthase
metformin/glimepiride combination	metformin/glimepiride combination	Laboratorios Silanes S.A. de C.V.	marketed	Biguanide/Sulfonylurea combination	AMP-activated protein kinase (AMPK) pathway; ATP-sensitive potassium channels (KATP)
Levosimendan infusion	Levosimendan infusion	AHEPA University Hospital	marketed	Calcium sensitizer / inodilator	Cardiac troponin C; ATP-sensitive potassium channels
Minoxidil 5 % Topical Spray	Minoxidil 5 % Topical Spray	Sheikh Zayed Federal Postgraduate Medical Institute	marketed	Potassium channel opener / Topical hair growth stimulant	ATP-sensitive potassium channels (KATP)
metformin, glyburide and glargine	metformin, glyburide and glargine	The University of Texas Health Science Center at San Antonio	marketed	Combination antidiabetic therapy (biguanide + sulfonylurea + basal insulin)	Multiple: AMP-activated protein kinase (metformin), ATP-sensitive potassium channels (glyburide), insulin receptor (glargine)
Sigmart (nicorandil)	Sigmart (nicorandil)	Merck KGaA, Darmstadt, Germany	marketed	Potassium channel opener with nitrate-like properties	ATP-sensitive potassium channels (KATP)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Potassium channel opener / topical hair growth stimulant class)

1. Mae Fah Luang University Hospital · 2 drugs in this class